Actinium Pharmaceuticals, Inc. (ATNM)
1.22
+0.03
(+2.52%)
USD |
NYAM |
Sep 18, 16:00
1.21
-0.01
(-0.82%)
After-Hours: 20:00
Actinium Pharmaceuticals Market Cap : 38.36M for Sept. 18, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 18, 2026 | 38.36M |
| September 17, 2026 | 37.42M |
| September 16, 2026 | 38.99M |
| September 15, 2026 | 39.30M |
| September 14, 2026 | 40.24M |
| September 11, 2026 | 44.02M |
| September 10, 2026 | 41.19M |
| September 09, 2026 | 38.67M |
| September 08, 2026 | 38.67M |
| September 04, 2026 | 32.38M |
| September 03, 2026 | 33.01M |
| September 02, 2026 | 31.44M |
| September 01, 2026 | 31.30M |
| August 31, 2026 | 32.07M |
| August 28, 2026 | 31.76M |
| August 27, 2026 | 31.44M |
| August 26, 2026 | 31.76M |
| August 25, 2026 | 33.96M |
| August 24, 2026 | 33.01M |
| August 21, 2026 | 34.59M |
| August 20, 2026 | 35.21M |
| August 19, 2026 | 35.53M |
| August 18, 2026 | 33.96M |
| August 17, 2026 | 33.01M |
| August 14, 2026 | 32.70M |
| Date | Value |
|---|---|
| August 13, 2026 | 30.31M |
| August 12, 2026 | 25.82M |
| August 11, 2026 | 24.94M |
| August 10, 2026 | 24.22M |
| August 07, 2026 | 25.07M |
| August 06, 2026 | 24.74M |
| August 05, 2026 | 23.54M |
| August 04, 2026 | 25.41M |
| August 03, 2026 | 25.46M |
| July 31, 2026 | 26.26M |
| July 30, 2026 | 26.26M |
| July 29, 2026 | 26.26M |
| July 28, 2026 | 27.19M |
| July 27, 2026 | 26.81M |
| July 24, 2026 | 26.98M |
| July 23, 2026 | 27.96M |
| July 22, 2026 | 28.24M |
| July 21, 2026 | 28.24M |
| July 20, 2026 | 27.70M |
| July 17, 2026 | 28.92M |
| July 16, 2026 | 27.92M |
| July 15, 2026 | 28.86M |
| July 14, 2026 | 28.08M |
| July 13, 2026 | 28.39M |
| July 10, 2026 | 29.18M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 4.697B |
| Alnylam Pharmaceuticals, Inc. | 32.04B |
| Anika Therapeutics, Inc. | 278.50M |
| Savara, Inc. | 1.103B |
| Vericel Corp. | 2.048B |
Market Cap Related Metrics
| PE Ratio | 3.420 |
| PS Ratio | 1.087 |
| Price to Book Value | 1.266 |
| Price | 1.22 |
| Earnings Yield | 29.24% |
| Operating PE Ratio | 3.991 |
| Normalized PE Ratio | 3.420 |